343 related articles for article (PubMed ID: 11694320)
21. JAK/STAT signaling pathway mediates cytokine-induced iNOS expression in primary astroglial cell cultures.
Dell'Albani P; Santangelo R; Torrisi L; Nicoletti VG; de Vellis J; Giuffrida Stella AM
J Neurosci Res; 2001 Sep; 65(5):417-24. PubMed ID: 11536325
[TBL] [Abstract][Full Text] [Related]
22. Expression of SOCS genes in normal and leukemic human leukocytes stimulated by prolactin, growth hormone and cytokines.
Dogusan Z; Hooghe-Peters EL; Berus D; Velkeniers B; Hooghe R
J Neuroimmunol; 2000 Sep; 109(1):34-9. PubMed ID: 10969179
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of cytokine-induced JAK-STAT signalling pathways by an endonuclease inhibitor aurintricarboxylic acid.
Chen CW; Chao Y; Chang YH; Hsu MJ; Lin WW
Br J Pharmacol; 2002 Dec; 137(7):1011-20. PubMed ID: 12429573
[TBL] [Abstract][Full Text] [Related]
24. Ethanol inhibits prolactin-induced activation of the JAK/STAT pathway in cultured astrocytes.
DeVito WJ; Stone S
J Cell Biochem; 1999 Aug; 74(2):278-91. PubMed ID: 10404396
[TBL] [Abstract][Full Text] [Related]
25. Effects of prolactin on signal transduction and gene expression: possible relevance for systemic lupus erythematosus.
Hooghe R; Dogusan Z; Martens N; Velkeniers B; Hooghe-Peters EL
Lupus; 2001; 10(10):719-27. PubMed ID: 11721698
[TBL] [Abstract][Full Text] [Related]
26. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
Tomic S; Chughtai N; Ali S
Mol Cell Endocrinol; 1999 Dec; 158(1-2):45-54. PubMed ID: 10630404
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
[TBL] [Abstract][Full Text] [Related]
28. Multiple prolactin (PRL) receptor cytoplasmic residues and Stat1 mediate PRL signaling to the interferon regulatory factor-1 promoter.
Wang Y; O'Neal KD; Yu-Lee L
Mol Endocrinol; 1997 Aug; 11(9):1353-64. PubMed ID: 9259325
[TBL] [Abstract][Full Text] [Related]
29. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
30. Tissue-specific induction of SOCS gene expression by PRL.
Tam SP; Lau P; Djiane J; Hilton DJ; Waters MJ
Endocrinology; 2001 Nov; 142(11):5015-26. PubMed ID: 11606470
[TBL] [Abstract][Full Text] [Related]
31. Interactions among Janus kinases and the prolactin (PRL) receptor in the regulation of a PRL response element.
Gao J; Hughes JP; Auperin B; Buteau H; Edery M; Zhuang H; Wojchowski DM; Horseman ND
Mol Endocrinol; 1996 Jul; 10(7):847-56. PubMed ID: 8813725
[TBL] [Abstract][Full Text] [Related]
32. Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo.
Hamanaka I; Saito Y; Yasukawa H; Kishimoto I; Kuwahara K; Miyamoto Y; Harada M; Ogawa E; Kajiyama N; Takahashi N; Izumi T; Kawakami R; Masuda I; Yoshimura A; Nakao K
Circ Res; 2001 Apr; 88(7):727-32. PubMed ID: 11304496
[TBL] [Abstract][Full Text] [Related]
33. Listeria monocytogenes modulates macrophage cytokine responses through STAT serine phosphorylation and the induction of suppressor of cytokine signaling 3.
Stoiber D; Stockinger S; Steinlein P; Kovarik J; Decker T
J Immunol; 2001 Jan; 166(1):466-72. PubMed ID: 11123325
[TBL] [Abstract][Full Text] [Related]
34. Association of 2',5'-oligoadenylate synthetase with the prolactin (PRL) receptor: alteration in PRL-inducible stat1 (signal transducer and activator of transcription 1) signaling to the IRF-1 (interferon-regulatory factor 1) promoter.
McAveney KM; Book ML; Ling P; Chebath J; Yu-Lee L
Mol Endocrinol; 2000 Feb; 14(2):295-306. PubMed ID: 10674401
[TBL] [Abstract][Full Text] [Related]
35. Receptor to nucleus signaling by prolactin and interleukin 2 via activation of latent DNA-binding factors.
Gilmour KC; Reich NC
Proc Natl Acad Sci U S A; 1994 Jul; 91(15):6850-4. PubMed ID: 8041708
[TBL] [Abstract][Full Text] [Related]
36. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
37. Activation of the Jak2-Stat5 signaling pathway in Nb2 lymphoma cells by an anti-apoptotic agent, aurintricarboxylic acid.
Rui H; Xu J; Mehta S; Fang H; Williams J; Dong F; Grimley PM
J Biol Chem; 1998 Jan; 273(1):28-32. PubMed ID: 9417042
[TBL] [Abstract][Full Text] [Related]
38. Prolactin potentiates insulin-stimulated leptin expression and release from differentiated brown adipocytes.
Viengchareun S; Bouzinba-Segard H; Laigneau JP; Zennaro MC; Kelly PA; Bado A; Lombès M; Binart N
J Mol Endocrinol; 2004 Dec; 33(3):679-91. PubMed ID: 15591027
[TBL] [Abstract][Full Text] [Related]
39. PRL receptor-mediated effects in female mouse adipocytes: PRL induces suppressors of cytokine signaling expression and suppresses insulin-induced leptin production in adipocytes in vitro.
Ling C; Billig H
Endocrinology; 2001 Nov; 142(11):4880-90. PubMed ID: 11606456
[TBL] [Abstract][Full Text] [Related]
40. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b.
Aoki N; Matsuda T
J Biol Chem; 2000 Dec; 275(50):39718-26. PubMed ID: 10993888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
